Loading the company…
Loading the company…
㈜두루약품
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Seoul, founded in 2001. Industry: Wholesale & Retail. Revenue for 2025 was ₩37.1bn. It has 10 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2020-09-23 · latest registration 2021-10-29 · newest first
본 발명의 일 실시 예는, 창고에서의 약품 박스 출고 및 운반이 자동으로 수행되도록 하는 기술을 제공한다. 본 발명의 실시 예에 따른 약품 배송을 위한 박스 이송 장치는, 창고의 내부에 저장된 박스를 전달 받아 이송시키는 제1이송부; 제1이송부와 결합하고, 박스에 부착된 코드체를 감지하며, 박스의 중량을 측정하는 제1센서부; 제1이송부와 결합하고, 제1이송부로부터 박스를 전달 받아 이송시키는 중간이송부; 중간이송부와 결합하고, 중간이송부로부터 박스를 전달 받아 이송 및 출고시키는 제2이송부; 및 제1센서부로부터 박스에 대한 정보를 전달 받아 분석하는 제어부;를 포함한다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 52.8 | 37.1 |
| Cost of sales | 49.7 | 35.0 |
| Gross profit (loss) | 3.1 | 2.1 |
| Selling, general and administrative expenses | 2.5 | 2.3 |
| Operating income (loss) | 0.6 | (0.2) |
| Non-operating income | 5.5 | 0.7 |
| Other gains | 0.1 | 0.0 |
| Finance income | 0.1 | 0.1 |
| Other | 5.3 | 0.6 |
| Non-operating expenses | 1.5 | 0.2 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 1.3 | 0.2 |
| Other | 0.2 | — |
| Profit (loss) before tax | 4.6 | 0.3 |
| Income tax expense | 0.3 | (0.1) |
| Net income (loss) | 4.4 | 0.4 |
Revenue ₩37.1bn, down 29.7% YoY.
Operating margin -0.5% (prior 1.1%).
Net income ₩0.4bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-06